OPKO HealthLTS:0KCS -2.88%56 14-Day RSI is 39.24 as of Jul. 11, 2026. GuruFocus rates LTS:0KCS with a GF Score™ of 56/100 and a GF Value™ of $1.06 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, OPKO Health ranks better than 61.93% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-11), OPKO Health's 14-Day RSI is 39.24.
The industry rank for OPKO Health's 14-Day RSI or its related term are showing as below:
LTS:0KCS's 14-Day RSI is ranked better than 61.93% of 218
companies
in the Medical Diagnostics & Research industry
Industry Median: 49.61
vs LTS:0KCS: 39.24
OPKO Health (LTS:0KCS) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
OPKO Health 14-Day RSI Related Terms
LTS:0KCS vs PSNL, CDNA, CSTL: 14-Day RSI Comparison
For the Diagnostics & Research subindustry, OPKO Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OPKO Health 14-Day RSI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where OPKO Health's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPKO Health (LTS:0KCS) has a 14-Day RSI of 39.24 as of Jul. 11, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on OPKO Health and its competitors. According to the industry distribution chart, OPKO Health ranks #83 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 38.1%.
Is OPKO Health's 14-Day RSI too high?
OPKO Health's current 14-Day RSI is 39.24. The Medical Diagnostics & Research industry median 14-Day RSI is 49.61. OPKO Health's value of 39.24 is 20.9% below this industry median. Based on the distribution chart, OPKO Health ranks #83 out of 218 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, OPKO Health has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's 14-Day RSI compare to PSNL and CDNA?
According to the Medical Diagnostics & Research industry distribution chart, OPKO Health ranks #83 out of 218 companies for 14-Day RSI. This puts OPKO Health in the upper half of its industry. The industry median 14-Day RSI is 49.61. OPKO Health's value of 39.24 is 20.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Diagnostics & Research company?
The median 14-Day RSI among Medical Diagnostics & Research companies is 49.61, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OPKO Health's current 14-Day RSI of 39.24 is 20.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on OPKO Health and its competitors. For the Medical Diagnostics & Research industry, the median 14-Day RSI is 49.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OPKO Health's current 14-Day RSI is 39.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (LTS:0KCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $1.35 — trading 27.4% above its estimated fair value. The current 14-Day RSI is 39.24 and 20.9% below the Medical Diagnostics & Research industry median of 49.61. OPKO Health's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For OPKO Health (LTS:0KCS), the current 14-Day RSI is 39.24 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OPKO Health (LTS:0KCS) Overvalued in 2026?
Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued.
The current stock price of $1.35 is trading 27.4% above its estimated GF Value™ of $1.06.
GuruFocus considers OPKO Health to be Modestly Overvalued.
Key valuation signals for LTS:0KCS:
14-Day RSI: 39.24
GF Value™: $1.06 vs. price of $1.35 (27.4% above fair value)
Industry Position: 20.9% below the Medical Diagnostics & Research median (#83 of 218)
No single metric tells the full story. See the LTS:0KCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
56GF Score
Get the complete analysis for LTS:0KCS
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0KCS has been successfully added to your 